WuXi XDC is trading at a price-to-earnings (P/E) ratio of 32 times, a significant premium over WuXi AppTec's 14 times.

Pharmaceutical company WuXi AppTec’s former Mendota Heights location is expected to close and 124 of its employees to be laid ...

WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on 18 March 2025.

Our forward-looking statements do not constitute any profit forecast by our management nor a undertaking by WuXi AppTec Co., Ltd. ("WuXi AppTec" or the "Company") to our investors. ACCORDINGLY ...

With the fate of the BIOSECURE Act currently in limbo, WuXi AppTec is looking on the brighter side for 2025. Still, geopolitical uncertainties under the second Trump administration loom large over ...

Medical device testing and consulting firm NAMSA is laying off dozens of employees after it acquired WuXi AppTec’s medtech testing division in St. Paul earlier this year. Christopher Rupp, NAMSA’s ...

WUXI APPTEC (02359.HK) announced the plan of repurchase of the company's A-shares through bidding for the second time in 2025 ...

China is ‘quickly ascending to biotechnology dominance’ and the US must ‘take swift action in the next three years’, the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

SHANGHAI, March 31, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life ...

[5] If the sum of the data below is inconsistent with the total, it is caused by rounding [6] If the sum of the data below is inconsistent with the total, it is caused by rounding ...